High-Precision Continuous Vital Signs Wearable Platform
The Corsano CardioWatch 287 is an advanced, medically certified wrist-worn monitoring bracelet designed to replace episodic manual spot-checks with seamless, continuous physiological intelligence across hospital wards, home care, and clinical trials.
Medically Validated Continuous Care & Research Device
Corsano delivers a real-time clinical monitoring platform enabled by the world’s most versatile medical smart bracelet. Designed for 24/7 patient comfort and clinical utility, CardioWatch 287 collects continuous physiological parameters while guaranteeing unrestricted raw data access for custom AI model co-development.
The device is prescription-only (Rx) for patient care and clinical trials, holding formal regulatory certifications to ensure immediate integration into accredited medical environments.
- CE-MDR Certified & FDA 510(k) Cleared for prescription healthcare deployment.
- Prescription-Grade Signal Integrity with continuous multi-sensor acquisition.
- ISO 13485 Manufactured in Switzerland & the Netherlands under strict medical QA.
- Open Data Standard supporting EMR/EHR sync and proprietary digital biomarker discovery.
End-to-End Cloud Platform & Multi-Sensor Intelligence
CardioWatch 287 combines wrist-worn hardware, secure gateway mobile SDKs, and a cloud-based research and clinical platform compliant with GDPR and HIPAA standards.
Seamless Data Access for Hospital IT and Clinical Investigators
Through Corsano’s open APIs and mobile SDKs (iOS/Android), patient physiological data can flow directly into hospital Electronic Medical Records (EMR) or partner analytical clouds without compromising patient data privacy.
Clinical trial sponsors can remotely configure monitoring parameters, set variable sampling intervals, and track patient compliance metrics in real-time through the dedicated Research Portal.
- Raw Data Access: Export raw PPG (Green, Red, Infrared), ECG, and ACC signals up to 128 Hz.
- Privacy-First Architecture: On-device encryption and GDPR/HIPAA compliant transport.
- Flexible Sampling: Customizable sampling frequency to balance signal fidelity and battery life.
Continuous Vital Sign Analytics from Multi-Sensor Fusion
CardioWatch 287 derives up to 19 vital sign parameters using synchronized multi-spectral sensors engineered for clinical accuracy.
Cuffless Non-Invasive Blood Pressure (NIBP)
Continuous cuffless blood pressure measurement validated according to ISO 81060-2:2019 and AAMI/ESH/ISO standards based on multi-patient arterial line reference datasets.
Single-Lead ECG & Rhythm
High-resolution single-lead ECG rhythm strips supporting automated arrhythmia continuous detection, QT/PR interval analysis, and HRV frequency domain metrics.
Multi-Spectral Optical PPG
Triple-wavelength PPG optical sensor array (Green, Red, Infrared) for continuous pulse rate, heart rate variability, SpO2 pulse oximetry, and pulse wave analysis.
Respiration Rate & Respiratory Dynamics
Derives continuous respiration rate from ECG impedance and optical PPG wave modulation, giving early signals of respiratory depression or distress.
Core Skin Temperature
Continuous high-accuracy thermal sensor tracking skin temperature fluctuations to assist in early sepsis identification, inflammation, and circadian tracking.
3-Axis Motion & Posture (GSR)
Integrated 3-axis accelerometer and Galvanic Skin Response (GSR) tracking physical activity, sleep staging, posture changes, and autonomic nervous stress response.
Key Advantages for Hospitals, CROs, and MedTech Partners
Designed to solve critical monitoring bottlenecks, CardioWatch 287 reduces manual nursing workload while eliminating blind spots in post-operative and ambulatory monitoring.
1. Clinically Validated Data Accuracy
Continuous vital sign measurements benchmarked against clinical gold standards, providing verified data quality suitable for Early Warning Scores (EWS) and regulatory submission.
2. Superior Signal Quality & Retention
Lightweight, ergonomic wristband design minimizes motion artifacts and avoids the high data-loss rates caused by lead detachment or bulky chest patches.
3. Real-Time Predictive Algorithms
Continuous input feeds predictive risk models, alerting medical staff to early signs of clinical deterioration, impending cardiac events, or septic onset hours before acute crisis.
4. Unrestricted Patient Mobility
Unobtrusive wrist form factor enables full patient mobility in general wards, preventing bed-rest complications and supporting faster post-surgical recovery.
5. Hospital-to-Home Continuum
The same device worn during hospital stay transitions to post-discharge remote monitoring, preserving baseline data continuity without patient re-onboarding.
6. Complete Raw Data Ownership
Unfiltered multi-sensor raw signal export gives biopharma and AI developers the exact foundation required to build and train proprietary digital biomarker models.
Certified Medical Device Infrastructure
Corsano Health operates under audited ISO 13485 quality systems. CardioWatch 287 is certified for deployment in medical institutions across North America, Europe, and global healthcare markets.
- CE-MDR Medical Device Regulation certified by Kiwa notified body.
- FDA 510(k) Clearance for prescription multi-parameter clinical monitoring.
- ISO 81060-2:2019 NIBP Standard clinical algorithm validation.
- Enterprise Security: End-to-end encrypted protocols conforming to HIPAA and GDPR requirements.
Frequently Asked Questions for Medical Buyers and Researchers
The CardioWatch 287 is an audited medical device holding full European CE-MDR certification and United States FDA 510(k) clearance. Manufacturing and software engineering follow strict ISO 13485 quality management standards.
Corsano’s Cuffless Non-Invasive Blood Pressure algorithm has been engineered using reference arterial line and ABPM data from over 500 patients. The continuous NIBP calculation was clinically validated in compliance with the universal ISO 81060-2:2019 standard.
Yes. Corsano provides unrestricted, IP-free export of raw multi-spectral PPG (Green, Red, Infrared), single-lead ECG rhythm, 3-axis accelerometer, temperature, and GSR signals sampled at up to 128 Hz via open Cloud REST APIs and native iOS/Android SDKs.
CardioWatch 287 data can be pushed into hospital EMR systems, nurse stations, or custom telemetry dashboards using our documented REST APIs and mobile gateways, allowing automated vital sign entry without disrupting clinical workflows.
The bracelet is designed for multi-day uninterrupted continuous wear with zero user intervention required. Its ultra-lightweight water-resistant enclosure ensures high patient compliance across elderly, pediatric, and acute care demographics.
Integrate CardioWatch 287 into Your Ward or Research Study
Talk with our medical device specialists and data engineers regarding procurement specifications, regulatory availability in your region, pilot trial programs, and SDK integration support.
Feature availability and specific physiological parameters may vary by country or region and are subject to local regulatory approvals, clearances, and medical device prescription requirements.